NUVA 44.25 Nuvasive Inc $NUVA Hit a 52 week high of 44.31

New Post Public Reply Private Reply Replies (0) Message Board
DennyT
NUVA 44.25 Nuvasive Inc $NUVA Hit a 52 week high of 44.31 Closing the day 09:45 at 44.25 +0.35 +0.80% With a day low of 43.91 and a total volume of 13,413.

NUVA Recent Posts: http://investorshangout.com/NuVasive-Inc-NUVA-54931/

NUVA Nuvasive Inc Recent Headline News

Shares of NUVA Up 23.1% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Mon Nov 17, 5:50PM CST
SmarTrend identified an Uptrend for NuVasive (NASDAQ:NUVA) on June 23rd, 2014 at $35.67. In approximately 5 months, NuVasive has returned 23.09% as of today's recent price of $43.90.
NUVA: 44.06 (+0.16)

NuVasive Earnings Review: 18 Days after Announcement Shares Up 11.5% (NUVA)
Comtex SmarTrend(R) - Mon Nov 17, 2:42PM CST
Two weeks ago on October 30th, 2014 NuVasive (NASDAQ:NUVA) reported earnings and analysts, on average, expected earnings of $0.25 on sales of $179.1 million. NuVasive actually reported earnings of $0.19 per share on sales of $189.9 million, missing EPS estimates by $0.06 and beating revenue estimates by $10.9 million. Since the company's report, shares of NuVasive have risen from $39.26 to $43.78, representing a gain of 11.5% in the past 18 days.
NUVA: 44.06 (+0.16)

NuVasive (NUVA) Flagged As Strong On High Volume
at The Street - Mon Nov 17, 9:00AM CST
Trade-Ideas LLC identified NuVasive (NUVA) as a strong on high relative volume candidate
NUVA: 44.06 (+0.16)

Upgrade Alert for NuVasive (NUVA)
Comtex SmarTrend(R) - Mon Nov 17, 7:55AM CST
NuVasive (NASDAQ:NUVA) was upgraded from Market Perform to Outperform at Wells Fargo today. The stock closed yesterday at $43.78 on volume of 481,000 shares, above average daily volume of 341,000. NuVasive has overhead space with shares priced $43.78, or 8.7% below the average consensus analyst price target of $47.93. The stock should discover initial support at its 50-day moving average (MA) of $37.43 and subsequent support at its 200-day MA of $35.89.
NUVA: 44.06 (+0.16)

NuVasive (NUVA) Shares March Higher, Can It Continue? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Nov 14, 7:13AM CST
NuVasive (NUVA) Shares March Higher, Can It Continue?
NUVA: 44.06 (+0.16)

NuVasive(R) Focused on Surgeon Support and Showcasing Industry-Leading Products at North American Spine Society 29th Annual Meeting
Marketwired - Mon Nov 10, 3:07PM CST
NuVasive, Inc. (NASDAQ: NUVA) ("NuVasive or the "Company" , a medical device company focused on developing minimally disruptive surgical products and procedures for the spine, today announced that it will attend the 29th North American Spine Society ("NASS" Annual Meeting, held November 12-15, 2014, at the Moscone Center in San Francisco, CA. The Company's attendance underscores NuVasive's ongoing commitment to surgeon support through numerous educational workshops and the exhibition of several of the Company's products and procedures that have revolutionized the spine industry.
NUVA: 44.06 (+0.16)

NuVasive Has Returned 18.5% Since SmarTrend Recommendation (NUVA)
Comtex SmarTrend(R) - Mon Nov 10, 12:55PM CST
SmarTrend identified an Uptrend for NuVasive (NASDAQ:NUVA) on June 23rd, 2014 at $35.67. In approximately 5 months, NuVasive has returned 18.46% as of today's recent price of $42.25.
NUVA: 44.06 (+0.16)

NuVasive Earnings Hindsight: Up 6.3% in Last 11 Days (NUVA)
Comtex SmarTrend(R) - Mon Nov 10, 11:41AM CST
11 days ago, on October 30th, 2014, NuVasive (NASDAQ:NUVA) reported its earnings. Analysts, on average, expected earnings of $0.25 per share on sales of $179.1 million. NuVasive actually reported earnings of $0.19 per share on sales of $189.9 million, missing EPS estimates by $0.06 and beating revenue estimates by $10.9 million. Since the company's report, shares of NuVasive have risen from $39.26 to $41.75, representing a gain of 6.3% in the past 11 days.
NUVA: 44.06 (+0.16)

Could This Obamacare Tax Be Repealed?
Sean Williams, The Motley Fool - Motley Fool - Sun Nov 09, 7:18AM CST
Source: White House on Flickr. With the midterm elections now in the rear-view mirror, Americans can begin speculating about the policies that will come  out of Washington over the next two years. Personally, I can't say I'm a huge fan of the...
ZMH: 111.55 (+0.87), BSX: 13.47 (+0.09), MDT: 71.94 (+2.75), NUVA: 44.06 (+0.16)

Update: NuVasive Q3 2014 Earnings
Andy Batts - at Seeking Alpha - Fri Nov 07, 3:09PM CST

NUVA: 44.06 (+0.16)

Insider Trading Alert - SANM, NUVA And EMC Traded By Insiders
at The Street - Wed Nov 05, 10:24AM CST
Stocks with insider trader activity include SANM, NUVA and EMC
EMC: 30.61 (+0.23), NUVA: 44.06 (+0.16), SANM: 24.91 (+0.26)

Republicans Grab Senate: Which Stocks Will Fare Well? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Nov 05, 8:19AM CST
The Republican win will certainly bolster stocks and give investors more chances to earn.
GD: 143.63 (+1.58), LMT: 185.58 (+0.07), MDT: 71.93 (+2.74), QDEL: 28.16 (+0.25), XOM: 95.06 (-0.05), CLF: 10.05 (-0.80), BA: 130.33 (+1.91), NUVA: 44.06 (+0.16), ANR: 2.47 (-0.14), BSX: 13.47 (+0.09), VLO: 49.76 (+0.04), BTU: 11.30 (-0.22), ABAX: 54.77 (+0.11), IMO: 47.81 (-0.17), ACI: 2.57 (-0.08)

NuVasive to Host Investor Morning on November 13, 2014
Marketwired - Mon Nov 03, 3:09PM CST
NuVasive, Inc. (NASDAQ: NUVA) ("NuVasive" or the "Company" , a medical device company focused on developing minimally disruptive surgical products and procedures for the spine, announced today that it will host a meeting for investors and analysts on Thursday, November 13, 2014 from 8:00 a.m. to 10:00 a.m. PT at the W Hotel in San Francisco, California.
NUVA: 44.06 (+0.16)

NuVasive Shares Up 16.2% Since SmarTrend's Buy Recommendation (NUVA)
Comtex SmarTrend(R) - Mon Nov 03, 9:57AM CST
SmarTrend identified an Uptrend for NuVasive (NASDAQ:NUVA) on June 23rd, 2014 at $35.67. In approximately 4 months, NuVasive has returned 16.22% as of today's recent price of $41.45.
NUVA: 44.06 (+0.16)

NuVasive spikes 3.8% after guidance update
Seeking Alpha - at Seeking Alpha - Fri Oct 31, 3:15PM CDT

NUVA: 44.06 (+0.16)

NuVasive's (NUVA) CEO Alex Lukianov on Q3 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Fri Oct 31, 12:15AM CDT

NUVA: 44.06 (+0.16)

NuVasive (NUVA) Q3 2014 Results - Earnings Call Webcast
SA Transcripts - at Seeking Alpha - Thu Oct 30, 4:25PM CDT

NUVA: 44.06 (+0.16)

NuVasive misses by $0.06, beats on revenue
Seeking Alpha - at Seeking Alpha - Thu Oct 30, 3:43PM CDT

NUVA: 44.06 (+0.16)

NuVasive Inc. (NUVA) Stock Research Links

NUVA Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Venice's Climate Challenge: Rising Seas, Sinking Lands

Updated Category News Views 3

Sea Rise Isn’t Just a Statistics Problem The ordeal of rising seas isn't just about staring at numbers in some spreadsheet, it's a real-world gut punch that's knocking at Venice's door. This city, known for its stunning architecture and winding canals, now serves as the poster child for what happens when Mother Nature and human errors leave a place on the brink of...

Continue Reading
Aetna's 2027 Medicare Plans: Comprehensive Outlook

Updated Category News Views 3

Unpacking Aetna's Medicare Strategy for 2027 Look, if there's one thing you should keep tabs on, it's how Aetna isn't just coasting by in the healthcare arena. These folks are pushing forward with new options for 2027 that prove they're serious about making healthcare not just accessible, but affordable across the board. Aetna, backed by CVS Health (NYSE: CVS), is making...

Continue Reading
Honeywell's Supply Line Snags Bait Class Action Risk

Updated Category News Views 8

Stepping into the chaos of the stock market sometimes feels like opening Pandora's box—just when you think you've seen it all, something new tumbles out. This time around, it's Honeywell Aerospace (NasdaqGS: HONA) playing catch with hot coals, and a burning class-action lawsuit smolders in the air. Deadline Looms for Investors in Class Action Heads up, folks! If you've...

Continue Reading
Vatrer Power: Lithium Batteries Revolutionize Golf Carts

Updated Category News Views 2

The humdrum world of golf carts just got a jolt of energy with lithium batteries entering the fray. Vatrer Power, the brain behind some nifty LiFePO4 lithium battery conversions, made some noise at this year's Golf Carting Expo & Dealer Summit in Charleston, South Carolina. Held at the North Charleston Convention Center, this trade show was the industry's premier...

Continue Reading
Govee Stirs Halloween Chills with New Sarah Gellar Ad

Updated Category News Views 4

Lighting Up Halloween the Hollywood Way When it comes to Halloween, folks go nuts driving up the thrill factor at home, and boy, has Govee nailed it this time around. They've dragged Sarah Michelle Gellar into their spooky mix, transforming homes into eerie masterpieces. And let's face it, who better than the 'Buffy the Vampire Slayer' herself to stir those spine-tingling...

Continue Reading
Kal Plastics Showcases at Design-2-Part Expo

Updated Category News Views 3

Kal Plastics Steps into the Limelight There's a buzz in the air, and it's all about Kal Plastics getting ready to strut their stuff at the Southern California Design-2-Part Show. Now, most folks probably don't spend their nights dreaming about thermoforming and pressure forming, but these guys sure make a case for it. They’ve got their eyes on impressing the crowd with...

Continue Reading
The Real Cost of Cabinet Decisions: Refinish or Replace?

Updated Category News Views 3

Uncovering the Truth Behind Cabinet Decisions When it comes to sprucing up a kitchen, most folks overlook what's hanging on their walls already: those tired old cabinets. Now, are you looking at chucking them out the window for brand-new ones, or can a fresh coat of paint breathe new life into them? Well, that's where Melvin Jones, a painting virtuoso from Lexington,...

Continue Reading
Ractigen's Breakthrough in DMD: RNA Activates Utrophin

Updated Category News Views 3

Ractigen's New Fight Against Duchenne: A Personal Take When it comes to biotech advancements, I've seen enough breakthroughs to not get swayed easily. But Ractigen Therapeutics presenting their first-in-human data on RNA activation for Duchenne Muscular Dystrophy (DMD) kind of demands your attention. Folks, they're talking about a potential shift in handling this brutal...

Continue Reading
Trading Platforms Poised for Billions by 2031

Updated Category News Views 4

Forecasts and Fierce Digital Landscapes Just when you thought the online trading realm was getting saturated, the numbers are making it clear: there’s still room for growth—even explosive growth. The online trading platform market is eyeing a hike, jumping from a $11.65 billion valuation in 2025 to a projected $18.18 billion by 2031, according to Mordor Intelligence....

Continue Reading

Top 5 Most Recently Viewed Articles

Beam Therapeutics Welcomes Sravan Emany as New CFO

Updated Category News Views 244

Beam Therapeutics Welcomes a New Chief Financial Officer Beam Therapeutics Inc. (Nasdaq: BEAM), a leader in developing precision genetic medicines, is heralding an important new chapter in its journey with the appointment of Sravan K. Emany as its Chief Financial Officer (CFO). Bringing vast experience from his previous roles in well-established corporations, Mr. Emany is...

Continue Reading
Northern 2 VCT PLC Update on Net Asset Value and Investments

Updated Category News Views 149

Northern 2 VCT PLC and Its Investment Journey Northern 2 VCT PLC is an established player in the venture capital sector, having been launched in 1999. As a Venture Capital Trust (VCT), it is dedicated to generating tax-efficient returns for investors through growth and dividends. This venture is managed by the experienced team at Mercia Fund Management Limited....

Continue Reading
Core Specialty Welcomes Evan Cabat as New CFO in Strategic Move

Updated Category News Views 232

Core Specialty Invests in Leadership with New CFO Core Specialty Insurance Holdings, Inc. has made a significant move by appointing Evan Cabat as its new Senior Vice President and Chief Financial Officer. This strategic decision is expected to enhance the company's financial leadership, leveraging Evan's extensive experience in the finance sector. Evan Cabat's Impressive...

Continue Reading
Zefiro's P&G Wins Major Well-Plugging Contract to Enhance Safety

Updated Category News Views 137

Zefiro's P&G Wins Major Well-Plugging Contract FORT LAUDERDALE, Fla. — ZEFIRO METHANE CORP. (Cboe Canada: ZEFI) (Frankfurt: Y6B) (OTCQB: ZEFIF) is celebrating a significant achievement through its subsidiary, Plants & Goodwin Inc. (P&G). Recently, P&G secured a substantial contract for an orphan well plugging project in Ohio. The initiative, financed by the Ohio...

Continue Reading
Max Stock Limited Announces Strong Q2 and First Half Performance

Updated Category News Views 142

Max Stock Limited Reports Impressive Financial Growth Max Stock Limited (TASE: MAXO) recently shared its second quarter and first half financial performance, indicating strong operational results amidst a challenging market environment. Key Financial Highlights The company declared a one-time dividend of ILS 40 million, which amounts to around ILS 0.29 per share. This...

Continue Reading